The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Facial Injectable Market Research Report 2024

Global Facial Injectable Market Research Report 2024

Publishing Date : Feb, 2024

License Type :
 

Report Code : 1906523

No of Pages : 77

Synopsis
Facial Injectable, also commonly known as Dermal Fillers, are the products used for aesthetic purposes such as anti-aging and enhancing the appearance of facial skin and help in a trending application known as bio-engineering or facial rejuvenation.
The global Facial Injectable market was valued at US$ 9678.8 million in 2023 and is anticipated to reach US$ 17690 million by 2030, witnessing a CAGR of 8.8% during the forecast period 2024-2030.
Geographically, North America dominated the facial injectable market driven by a high number of aged and adult population, higher awareness, higher spending on such treatment, presence of world class infrastructure and service providers and stringent guidelines in the region.
This report aims to provide a comprehensive presentation of the global market for Facial Injectable, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Facial Injectable.
Report Scope
The Facial Injectable market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Facial Injectable market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Facial Injectable companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bloomega BioTechnology
Allergan
Merz Pharma
Bausch Health
Galderma
Integra Lifesciences
Tei Biosciences
Fibrogen
Segment by Type
Hyaluronic Acid
Collagen
Botulinum Toxin
Polymers
Particles
Segment by Application
Hospitals
Clinics
Research
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Facial Injectable companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Facial Injectable Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Hyaluronic Acid
1.2.3 Collagen
1.2.4 Botulinum Toxin
1.2.5 Polymers
1.2.6 Particles
1.3 Market by Application
1.3.1 Global Facial Injectable Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Research
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Facial Injectable Market Perspective (2019-2030)
2.2 Facial Injectable Growth Trends by Region
2.2.1 Global Facial Injectable Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Facial Injectable Historic Market Size by Region (2019-2024)
2.2.3 Facial Injectable Forecasted Market Size by Region (2025-2030)
2.3 Facial Injectable Market Dynamics
2.3.1 Facial Injectable Industry Trends
2.3.2 Facial Injectable Market Drivers
2.3.3 Facial Injectable Market Challenges
2.3.4 Facial Injectable Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Facial Injectable Players by Revenue
3.1.1 Global Top Facial Injectable Players by Revenue (2019-2024)
3.1.2 Global Facial Injectable Revenue Market Share by Players (2019-2024)
3.2 Global Facial Injectable Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Facial Injectable Revenue
3.4 Global Facial Injectable Market Concentration Ratio
3.4.1 Global Facial Injectable Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Facial Injectable Revenue in 2023
3.5 Facial Injectable Key Players Head office and Area Served
3.6 Key Players Facial Injectable Product Solution and Service
3.7 Date of Enter into Facial Injectable Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Facial Injectable Breakdown Data by Type
4.1 Global Facial Injectable Historic Market Size by Type (2019-2024)
4.2 Global Facial Injectable Forecasted Market Size by Type (2025-2030)
5 Facial Injectable Breakdown Data by Application
5.1 Global Facial Injectable Historic Market Size by Application (2019-2024)
5.2 Global Facial Injectable Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Facial Injectable Market Size (2019-2030)
6.2 North America Facial Injectable Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Facial Injectable Market Size by Country (2019-2024)
6.4 North America Facial Injectable Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Facial Injectable Market Size (2019-2030)
7.2 Europe Facial Injectable Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Facial Injectable Market Size by Country (2019-2024)
7.4 Europe Facial Injectable Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Facial Injectable Market Size (2019-2030)
8.2 Asia-Pacific Facial Injectable Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Facial Injectable Market Size by Region (2019-2024)
8.4 Asia-Pacific Facial Injectable Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Facial Injectable Market Size (2019-2030)
9.2 Latin America Facial Injectable Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Facial Injectable Market Size by Country (2019-2024)
9.4 Latin America Facial Injectable Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Facial Injectable Market Size (2019-2030)
10.2 Middle East & Africa Facial Injectable Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Facial Injectable Market Size by Country (2019-2024)
10.4 Middle East & Africa Facial Injectable Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bloomega BioTechnology
11.1.1 Bloomega BioTechnology Company Detail
11.1.2 Bloomega BioTechnology Business Overview
11.1.3 Bloomega BioTechnology Facial Injectable Introduction
11.1.4 Bloomega BioTechnology Revenue in Facial Injectable Business (2019-2024)
11.1.5 Bloomega BioTechnology Recent Development
11.2 Allergan
11.2.1 Allergan Company Detail
11.2.2 Allergan Business Overview
11.2.3 Allergan Facial Injectable Introduction
11.2.4 Allergan Revenue in Facial Injectable Business (2019-2024)
11.2.5 Allergan Recent Development
11.3 Merz Pharma
11.3.1 Merz Pharma Company Detail
11.3.2 Merz Pharma Business Overview
11.3.3 Merz Pharma Facial Injectable Introduction
11.3.4 Merz Pharma Revenue in Facial Injectable Business (2019-2024)
11.3.5 Merz Pharma Recent Development
11.4 Bausch Health
11.4.1 Bausch Health Company Detail
11.4.2 Bausch Health Business Overview
11.4.3 Bausch Health Facial Injectable Introduction
11.4.4 Bausch Health Revenue in Facial Injectable Business (2019-2024)
11.4.5 Bausch Health Recent Development
11.5 Galderma
11.5.1 Galderma Company Detail
11.5.2 Galderma Business Overview
11.5.3 Galderma Facial Injectable Introduction
11.5.4 Galderma Revenue in Facial Injectable Business (2019-2024)
11.5.5 Galderma Recent Development
11.6 Integra Lifesciences
11.6.1 Integra Lifesciences Company Detail
11.6.2 Integra Lifesciences Business Overview
11.6.3 Integra Lifesciences Facial Injectable Introduction
11.6.4 Integra Lifesciences Revenue in Facial Injectable Business (2019-2024)
11.6.5 Integra Lifesciences Recent Development
11.7 Tei Biosciences
11.7.1 Tei Biosciences Company Detail
11.7.2 Tei Biosciences Business Overview
11.7.3 Tei Biosciences Facial Injectable Introduction
11.7.4 Tei Biosciences Revenue in Facial Injectable Business (2019-2024)
11.7.5 Tei Biosciences Recent Development
11.8 Fibrogen
11.8.1 Fibrogen Company Detail
11.8.2 Fibrogen Business Overview
11.8.3 Fibrogen Facial Injectable Introduction
11.8.4 Fibrogen Revenue in Facial Injectable Business (2019-2024)
11.8.5 Fibrogen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’